Westlake Chemical Partners (WLKP) Q4 2025 earnings summary

Executive summary

• Full year 2025 net income attributable to the partnership was $48.7 million ($1.38 per unit), with consolidated net income of $299 million, reflecting stable results despite the planned Petro 1 turnaround.

• Fourth quarter 2025 net income was $15 million ($0.41 per unit), nearly flat year-over-year and sequentially.

• The fixed margin Ethylene Sales Agreement for 95% of annual planned production insulated results from market volatility, supporting predictable earnings and cash flows.

• Achieved 46 consecutive quarterly distributions since IPO in 2014, with no reductions and a 71% increase in distributions since inception.

Financial highlights

• Full year 2025 distributable cash flow was $53.4 million, down $13.5 million from 2024, mainly due to lower production and sales volumes from the planned turnaround.

• Fourth quarter 2025 distributable cash flow was $19 million, up $4 million year-over-year due to lower maintenance capex.

• Full year 2025 cash flows from operating activities totaled $280.5 million, a decrease of $204.5 million from 2024, primarily due to turnaround expenditures.

• EBITDA for 2025 was $450.0 million, compared to $507.6 million in 2024.

• Distribution coverage for 2025 was 0.8x, reflecting the impact of the turnaround.

Outlook and guidance

• No planned turnarounds in 2026; production and sales volumes expected to recover, driving distributable cash flow and coverage ratio back to historical levels.

• Coverage ratio expected to rise above 1.1x in 2026, replenishing operating surplus and investment balances.